These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31683241)

  • 21. Patient engagement, treatment preferences and shared decision-making in the treatment of opioid use disorder in adults: a scoping review protocol.
    Marshall T; Kinnard EN; Hancock M; King-Jones S; Olson K; Abba-Aji A; Rittenbach K; Vohra S
    BMJ Open; 2018 Oct; 8(10):e022267. PubMed ID: 30337310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire.
    Franken IH; Hendriksa VM; van den Brink W
    Addict Behav; 2002; 27(5):675-85. PubMed ID: 12201376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review.
    Rice DB; Hutton B; Poulin P; Sproule BA; Wolfe D; Moher D; Thavorn K; Garber G; Taha S; Porath A; Willows M; Esmaeilisaraji L; Yazdi F; Shea B; Skidmore B; Corace K
    BMJ Open; 2018 Oct; 8(10):e023902. PubMed ID: 30341139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse childhood experiences predict autonomic indices of emotion dysregulation and negative emotional cue-elicited craving among female opioid-treated chronic pain patients.
    Garland EL; Reese SE; Bedford CE; Baker AK
    Dev Psychopathol; 2019 Aug; 31(3):1101-1110. PubMed ID: 31060644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of care for HIV and opioid use disorder.
    Oldfield BJ; Muñoz N; McGovern MP; Funaro M; Villanueva M; Tetrault JM; Edelman EJ
    AIDS; 2019 Apr; 33(5):873-884. PubMed ID: 30882491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure.
    Peck KR; Schumacher JA; Stasiewicz PR; Coffey SF
    J Trauma Stress; 2018 Jun; 31(3):373-382. PubMed ID: 29786898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Craving for Ketamine and Its Relationship With Clinical Outcome Indicators in Males With Ketamine Use Disorder.
    Wang PW; Lin HC; Liu TL; Hsu CY; Yang YY; Wu HC; Yen CF
    Front Psychiatry; 2021; 12():476205. PubMed ID: 34168574
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of emotion dysregulation in the relation of childhood trauma to heroin craving in individuals with heroin dependence.
    Ghorbani F; Khosravani V; Mohammadzadeh A; Shadnia S
    Drug Alcohol Depend; 2019 Feb; 195():132-139. PubMed ID: 30634108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric evaluation of a Swedish version of the Shortened Desires for Alcohol Questionnaire (Shortened-DAQ).
    Khemiri L; Jayaram-Lindström N; Hammarberg A
    J Subst Abuse Treat; 2017 Aug; 79():61-66. PubMed ID: 28673529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopsychosocial determinants of opioid use disorder (OUD) and implications for maternal and child health research: A scoping review.
    Salihu HM; Salinas A; Medina I; Krishnaswami J; Aliyu MH
    J Opioid Manag; 2019; 15(1):77-91. PubMed ID: 30855725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep moderates the relationship between stress and craving in individuals with opioid use disorder.
    Teeters JB; Jones JL; Jarnecke AM; Back SE
    Exp Clin Psychopharmacol; 2021 Aug; 29(4):418-426. PubMed ID: 32297784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.
    Huhn AS; Sweeney MM; Brooner RK; Kidorf MS; Tompkins DA; Ayaz H; Dunn KE
    Neuropsychopharmacology; 2019 Mar; 44(4):826-833. PubMed ID: 30375498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations.
    Speed TJ; Parekh V; Coe W; Antoine D
    Int Rev Psychiatry; 2018 Oct; 30(5):136-146. PubMed ID: 30398071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attentional bias in opioid users: A systematic review and meta-analysis.
    MacLean RR; Sofuoglu M; Brede E; Robinson C; Waters AJ
    Drug Alcohol Depend; 2018 Oct; 191():270-278. PubMed ID: 30157467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of the Korean Version of the CAGE-Adapted to Include Drugs Combined With Clinical Predictors to Screen for Opioid-Related Aberrant Behavior.
    Lee CS; Kim D; Park SY; Lee SC; Kim YC; Moon JY
    Anesth Analg; 2019 Sep; 129(3):864-873. PubMed ID: 31425231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    Hermes G; Hyman SM; Fogelman N; Kosten TR; Sinha R
    Am J Addict; 2019 Nov; 28(6):480-488. PubMed ID: 31448846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder.
    Huhn AS; Strain EC; Tompkins DA; Dunn KE
    Drug Alcohol Depend; 2018 Dec; 193():142-147. PubMed ID: 30384321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An interventionist adherence scale for a specialized brief negotiation interview focused on treatment engagement for opioid use disorders.
    Pantalon MV; Dziura J; Li FY; Owens PH; O'Connor PG; D'Onofrio G
    Subst Abus; 2017; 38(2):191-199. PubMed ID: 28398192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of anxiety sensitivity on opioid use disorder treatment outcomes.
    Baxley C; Weinstock J; Lustman PJ; Garner AA
    Exp Clin Psychopharmacol; 2019 Feb; 27(1):64-77. PubMed ID: 30080059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.